Serious manifestations of respiratory virus infections such as influenza and coronavirus
disease 2019 (COVID-19) are associated with a dysregulated immune response and …

Cancer patients, due to their immunocompromised status, are at an increased risk for severe
SARS-CoV-2 infection. Since severe SARS-CoV-2 infection causes multiple organ damage …

Abstract While The World Health Organization (WHO) has announced that COVID-19 is no
longer a public health emergency of international concern (PHEIC), the risk of reinfection …

COVID-19 emerged in December 2019 in Wuhan, China, spread worldwide rapidly, and
caused millions of deaths in a short time. Many preclinical and clinical studies were …

Background: Many clinical trials have reported the use of mesenchymal stromal cells
(MSCs) following the indication of severe SARS-CoV-2 infection. However, in the COVID19 …

Stem cell therapy has emerged as a promising avenue for regenerative medicine, offering
the potential to treat a wide range of debilitating diseases and injuries. Among the various …

Abstract Background The STROMA-CoV-2 study was a French phase 2b, multicenter,
double-blind, randomized, placebo-controlled clinical trial that did not identify a significant …

Several ongoing investigations have been founded on the development of an optimized
therapeutic strategy for the COVID-19 virus as an undeniable acute challenge for human life …

Abstract Purpose of Review The landscape of the coronavirus disease 2019 (COVID-19)
pandemic has rapidly changed over the past 3 years. Paralleling this evolution, the scientific …

Mesenchymal stem cells (MSCs) have tantalized regenerative medicine with their
therapeutic potential, yet a cloud of controversies looms over their clinical tran splantation …